Which compounded semaglutide products have been recalled?
Which compounded semaglutide products have been recalled?
openFDA lists 52 recall reports for compounded or unapproved semaglutide products from 14 firms as of Nov 15, 2026, 19 of them initiated in 2026; all are Class II. The most common reason FDA recorded is “Lack of assurance of sterility,” and the most recent report was initiated Sep 10, 2026 by Carolina Infusion, LLC.
Semaglutide recall reports by firm
| Apollo Care, LLC | 11 |
| ProRx LLC | 10 |
| AEQUITA PHARMACY | 6 |
| Carolina Infusion, LLC | 6 |
| Boothwyn Pharmacy LLC | 3 |
| Thrive Health and Wellness, LLC | 3 |
| GenoGenix LLC | 2 |
| Harbin Jixianglong Biotech Co., Ltd. | 2 |
| New Life Pharma LLC | 2 |
| Pharmacy Plus, Inc. dba Vital Care Compounder | 2 |
| TMC Acquisition LLC dba Tailor Made Compounding | 2 |
| PAYLESS COMPOUNDERS, LLC | 1 |
| Pharmacy Innovations | 1 |
| TMC Acquisitions LLC dba Tailor Made Compounding | 1 |
Semaglutide recall reports by reason
| Lack of assurance of sterility | 30 |
| Presence of particulate matter | 11 |
| Lack of processing controls | 6 |
| Subpotent drug | 3 |
| CGMP deviations | 2 |
Semaglutide recall reports
Quantities are as the firm reported them to FDA: 50 of 52 reports give one.
| Record | ||||||
|---|---|---|---|---|---|---|
| Sep 10, 2026 | Carolina Infusion, LLC | SEMAGLUTIDE/CYANOCOBALAMIN 9/2 MG/ML INJECTABLE, Packaged in single-use dosage syringes, total mL dispensed based on dosage per specific ... | 82.9 mls - in patient specific syringe dose | Lack of Assurance of Sterility: Related to formulation using bacteriostic water; Related to processing equipment used... | Class II | D-0026-2027 |
| Sep 10, 2026 | Carolina Infusion, LLC | SEMAGLUTIDE/CYANOCOBALAMIN 3/2 MG/ML INJECTABLE, Packaged in single-use dosage syringes, total mL dispensed based on dosage per specific... | 57.0 mls - in patient specific syringe doses | Lack of Assurance of Sterility: Related to formulation using bacteriostic water; Related to processing equipment used... | Class II | D-0019-2027 |
| Sep 10, 2026 | Carolina Infusion, LLC | SEMAGLUTIDE 3 MG/ML INJECTABLE, 8 x 0.1 mL syringes, Carolina Infusion LLC, 95 Bees Creek Road, Ridgeland, SC 29936 | 8 x 0.1 ml syringes | Lack of Assurance of Sterility: Related to formulation using bacteriostic water; Related to processing equipment used... | Class II | D-0018-2027 |
| Jul 29, 2026 | Apollo Care, LLC | SEMAGLUTIDE 7.5mg (5mg/mL), Glycine 7.5 mg (5mg/mL), 1.5 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Only, APOLLO car... | 250 vials. | Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material | Class II | D-0755-2026 |
| Jul 29, 2026 | Apollo Care, LLC | SEMAGLUTIDE 12.5MG (2.5MG/mL), 5 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Only, APOLLO care, 3801 Mojave Ct, Ste 1... | 56,918 vials. | Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material | Class II | D-0747-2026 |
| Jul 29, 2026 | Apollo Care, LLC | SEMAGLUTIDE 2.25MG (0.9 mg/mL), 2.5 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Only, APOLLO care, 3801 Mojave Ct, St... | 23,029 vials. | Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material | Class II | D-0748-2026 |
| Jul 29, 2026 | Apollo Care, LLC | SEMAGLUTIDE 2.5mg (1mg/mL), Glycine 12.5 mg (5mg/mL), 2.5 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Only, APOLLO ca... | 250 vials. | Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material | Class II | D-0753-2026 |
| Jul 29, 2026 | Apollo Care, LLC | SEMAGLUTIDE 6.75mg (4.5 mg/mL), 1.5 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Only, APOLLO care, 3801 Mojave Ct, St... | 37,546 vials. | Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material | Class II | D-0749-2026 |
| Jul 29, 2026 | Apollo Care, LLC | SEMAGLUTIDE 0.9mg (0.9 mg/mL), 1 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Only, APOLLO care, 3801 Mojave Ct, Ste 1... | 4,748 vials. | Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material | Class II | D-0752-2026 |
| Jul 29, 2026 | Apollo Care, LLC | SEMAGLUTIDE 20mg (5mg/mL), Glycine 20 mg (5mg/mL), 4 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Only, APOLLO care, 3... | 4,250 vials. | Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material | Class II | D-0757-2026 |
| Jul 29, 2026 | Apollo Care, LLC | SEMAGLUTIDE 10mg (5mg/mL), Glycine 10 mg (5mg/mL), 2 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Only, APOLLO care, 3... | 500 vials. | Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material | Class II | D-0756-2026 |
| Jul 29, 2026 | Apollo Care, LLC | SEMAGLUTIDE 9mg (4.5 mg/mL), 2 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Only, APOLLO care, 3801 Mojave Ct, Ste 102... | 24,608 vials. | Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material | Class II | D-0751-2026 |
| Jul 29, 2026 | Apollo Care, LLC | SEMAGLUTIDE 4.5mg (0.9 mg/mL), 5 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Only, APOLLO care, 3801 Mojave Ct, Ste 1... | 9,762 vials. | Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material | Class II | D-0750-2026 |
| Jul 29, 2026 | Apollo Care, LLC | SEMAGLUTIDE 5mg (1mg/mL), Glycine 25 mg (5mg/mL), 5 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Only, APOLLO care, 38... | 250 vials. | Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material | Class II | D-0754-2026 |
| Mar 6, 2026 | PAYLESS COMPOUNDERS, LLC | Semaglutide-Glycine-Cyanocobalamin Injectable, 2.5 mg, 5 mg, 1 MG/ML, 0.5 mL vials, Rx only, Northwest Compounders, Beaverton, OR | 91 vials | Lack of Assurance of Sterility | Class II | D-0471-2026 |
| Feb 26, 2026 | New Life Pharma LLC | Semaglutide Inj., 2 mg x 5, Sterile Multi-Dose Vial, Rx only, Nomida, 25055 W Valley Pkwy, Suite 106, Olathe, KS 66061, NDC 84223-001-06 | 2 vials | Lack of Assurance of Sterility | Class II | D-0393-2026 |
| Feb 26, 2026 | New Life Pharma LLC | Semaglutide Inj, 2mg x 10, Sterile Multi-Dose Vial, Rx only, Nomida, 25055 W Valley Pkwy, Suite 106, Olathe, KS 66061, NDC 84223-001-07. | 820 vials | Lack of Assurance of Sterility | Class II | D-0392-2026 |
| Feb 13, 2026 | Harbin Jixianglong Biotech Co., Ltd. | Semaglutide, For Rx compounding use only, packaged in a) 1g, NDC 84385-106-01; b) 5g, NDC 84385-106-02; c) 10g, NDC 84385-106-06; d) 25g... | N/A | CGMP Deviations This recall has been initiated due to failing to complete process validation and bacterial endotoxin ... | Class II | D-0380-2026 |
| Feb 13, 2026 | Harbin Jixianglong Biotech Co., Ltd. | Semaglutide, For Rx compounding use only, packaged in a) 1g, NDC 84385-106-01; b) 5g, NDC 84385-106-02; c) 10g, NDC 84385-106-06; d) 25g,... | N/A | CGMP Deviations This recall has been initiated due to failing to complete process validation and bacterial endotoxin ... | Class II | D-0379-2026 |
| Oct 15, 2025 | ProRx LLC | Semaglutide Injection, 10 mg/4 mL (2.5 mg/mL), 4mL Multidose Vial, For Subcutaneous Use, Rx Only, Mfd by: ProRx, 619 Jeffers Cir, Exton, ... | 8,400 vials | Lack of Assurance of Sterility | Class II | D-0115-2026 |
| Oct 15, 2025 | ProRx LLC | Semaglutide Injection, 6mg/2.4mL (2.5 mg/mL), 2.4mL Multidose Vial, For Subcutaneous Use, Rx Only, Mfd by: ProRx, 619 Jeffers Cir, Exton,... | 8,310 vials | Lack of Assurance of Sterility | Class II | D-0116-2026 |
| Oct 15, 2025 | ProRx LLC | Semaglutide Injection, 2.5mg/1mL (2.5 mg/mL), 1mL Multidose Vial, For Subcutaneous Use, Rx Only, Mfd by: ProRx, 619 Jeffers Cir, Exton, P... | 2,649 vials | Lack of Assurance of Sterility | Class II | D-0118-2026 |
| Oct 15, 2025 | ProRx LLC | Semaglutide Injection, 8mg/3.2mL (2.5 mg/mL), 3.2mL Multidose Vial, For Subcutaneous Use, Rx Only, Mfd by: ProRx, 619 Jeffers Cir, Exton,... | 11,119 vials | Lack of Assurance of Sterility | Class II | D-0117-2026 |
| Oct 15, 2025 | ProRx LLC | Semaglutide Injection, 12.5/5mL (2.5 mg/mL), 5mL Multidose Vial, For Subcutaneous Use, Rx Only, Mfd by: ProRx, 619 Jeffers Cir, Exton, PA... | 2,809 vials | Lack of Assurance of Sterility | Class II | D-0114-2026 |
| Oct 15, 2025 | ProRx LLC | Semaglutide Injection, 5 mg/2 mL (2.5 mg/mL), 2mL Multidose Vial, For Subcutaneous Use, Rx Only, Mfd by: ProRx, 619 Jeffers Cir, Exton, P... | 2,805 vials | Lack of Assurance of Sterility | Class II | D-0119-2026 |
| Jul 30, 2025 | GenoGenix LLC | Semaglutide for Injection, a) 20 mg b) 20 mg/mL, 10 mL Multi-Dose Vials, GenoGenix, LLC, 2840 NW 2nd Ave Ste 204 Boca Raton, FL 33431-669... | Not given | Lack of Assurance of Sterility | Class II | D-0091-2026 |
| Jul 30, 2025 | GenoGenix LLC | Semaglutide with B12 for Injection, all strengths and presentations, GenoGenix, LLC, 2840 NW 2nd Ave Ste 204 Boca Raton, FL 33431-6692. | Not given | Lack of Assurance of Sterility | Class II | D-0083-2026 |
| Jul 18, 2025 | AEQUITA PHARMACY | Semaglutide +Cyanocobalamin 1.5 mg + 0.25mg/0.5 mL Inj Sol, Inject 0.5 mL (50 units on syringe) subcutaneously, Sterile, 2 mL Multi Dose ... | 190 vials | Lack of Processing Controls. | Class II | D-0563-2025 |
| Jul 18, 2025 | AEQUITA PHARMACY | Semaglutide + Cyanocobalamin injection solution, 2.21 mg + 0.25mg/0.5 mL Inj Sol, Inject 0.5 mL (50 units on syringe) subcutaneously, Ste... | 176 vials | Lack of Processing Controls. | Class II | D-0564-2025 |
| Jul 18, 2025 | AEQUITA PHARMACY | Semaglutide + Cyanocobalamin 0.88 mg + 0.25mg/0.5 mL Inj Sol, Inject 0.5 mL (50 units on syringe) subcutaneously, Sterile, 2 mL Multi Dos... | 194 vials | Lack of Processing Controls. | Class II | D-0562-2025 |
| Jul 18, 2025 | AEQUITA PHARMACY | Semaglutide + Cyanocobalamin 0.22 mg + 0.25mg/0.5 ml Inj Sol, Inject 0.5 mL (50 units on syringe) subcutaneously, Sterile, Multi Dose Via... | 290 vials | Lack of Processing Controls. | Class II | D-0553-2025 |
| Jul 18, 2025 | AEQUITA PHARMACY | Semaglutide + Cyanocobalamin 0.44 mg + 0.25mg/0.5 mL Inj Sol, Inject 0.5 mL (50 units on syringe) subcutaneously, Sterile, 2 mL Multi Do... | 221 vials | Lack of Processing Controls. | Class II | D-0561-2025 |
| Jul 18, 2025 | AEQUITA PHARMACY | Semaglutide + Cyanocobalamin 2.67 mg + 0.25mg/0.5 mL Inj Sol, Inject 0.5 mL (50 units on syringe) subcutaneously, Sterile, 2 mL Multi Dos... | 158 vials | Lack of Processing Controls. | Class II | D-0565-2025 |
| Jul 9, 2025 | Boothwyn Pharmacy LLC | Semaglutide, 2.5 mg/mL injection, 0.8 mL, Boothwyn Pharmacy | 186 vials | Subpotent Drug | Class II | D-0608-2025 |
| Jul 9, 2025 | Boothwyn Pharmacy LLC | Semaglutide, 2.5 mg/mL injection, 2 mL., Boothwyn Pharmacy | 642 vials | Subpotent Drug | Class II | D-0606-2025 |
| Jul 9, 2025 | Boothwyn Pharmacy LLC | Semaglutide, 2.5 mg/mL injection, 4 mL, Boothwyn Pharmacy | 648 vials | Subpotent Drug | Class II | D-0609-2025 |
| May 21, 2025 | Thrive Health and Wellness, LLC, dba Thrive Health Solutions (Colorado) | Semaglutide, 5 mg/mL, pre-filled syringe, Thrive Health Solutions, 88 Inverness, Cir E, Suite A-204, Englewood, CO 80112 | 164 syringes | Lack of Assurance of Sterility | Class II | D-0480-2025 |
| May 21, 2025 | Thrive Health and Wellness, LLC, dba Thrive Health Solutions (Colorado) | Semaglutide, 2.5 mg/mL, pre-filled syringe, Thrive Health Solutions, 88 Inverness, Cir E, Suite A-204, Englewood, CO 80112 | 32 syringes | Lack of Assurance of Sterility | Class II | D-0479-2025 |
| May 21, 2025 | Thrive Health and Wellness, LLC, dba Thrive Health Solutions (Colorado) | Semaglutide/Cyanocobalamin Injectable, 5mg/1mg/mL, pre-filled syringe, Thrive Health Solutions, 88 Inverness, Cir E, Suite A-204, Englewo... | 28 syringes | Lack of Assurance of Sterility | Class II | D-0481-2025 |
| Aug 22, 2024 | ProRx LLC | Semaglutide, 2 mL (2.5mg/mL), Compounded RX Product, Multidose SC inj, glass vial, ProRx, 267-565-7008, NDC 84139-225-01 | 2,490 vials | Lack of Assurance of Sterility | Class II | D-0650-2024 |
| Aug 22, 2024 | ProRx LLC | Semaglutide / Cyanocobalamin Injection: 2.5/0.5 mg/mL, 2 mL Multiple Dose Vial, Compounded Rx Product, ProRX 267-565-7008, NDC 84139-225-02 | 500 vials | Lack of Assurance of Sterility | Class II | D-0654-2024 |
| Aug 22, 2024 | ProRx LLC | SEMAGLUTIDE 5mg/2mL (2.5mg/mL), Rx Only 2 mL Multiple Dose Vial, Rx Only, Compounded Drug, Mfd by: ProRX Exton, PA19341, NDC 84139-225-01 | 8,396 vials | Lack of Assurance of Sterility | Class II | D-0652-2024 |
| Aug 22, 2024 | ProRx LLC | SEMAGLUTIDE 10mg/4mL (2.5mg/mL), 4 mL Multiple Dose Vial, Rx Only, Compounded Drug, Mfd by: ProRX Exton, PA19341, NDC 84139-225-04 | 1,960 vials | Lack of Assurance of Sterility | Class II | D-0653-2024 |
| Aug 15, 2023 | TMC Acquisitions LLC dba Tailor Made Compounding | Semaglutide/Cyanocobalamin 2mg/0.4mg/mL, 1mLvials, Tailor Made Compounding. | 9 vials | Lack of Assurance of Sterility | Class II | D-1105-2023 |
| Apr 13, 2023 | Pharmacy Plus, Inc. dba Vital Care Compounder | C-Semaglutide 5mg/mL injection, 0.5mL vials, Rx only, Vital Care Compounder 115 South 40th Ave, Suite A Hattiesburg, MS 39402 | 45 vials | Lack of assurance of sterility. | Class II | D-0538-2023 |
| Dec 22, 2022 | Pharmacy Innovations | SEMAGLUTIDE 0.5MG/ML (0.5ML VIAL) INJECTABLE SEMAGLUTIDE 1MG/ML (0.5ML VIAL) INJECTABLE SEMAGLUTIDE 2MG/ML (0.5ML VIAL) INJECTABLE SEMAGL... | N/A | Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility. | Class II | D-0236-2023 |
| Oct 7, 2022 | Pharmacy Plus, Inc. dba Vital Care Compounder | SEMAGLUTIDE INJECTION 5MG/ML (0.25MG/0.05ML) SOLN, various amounts in unit dose vials, Rx only, Vital Care Compounder, 115 S. 40th Ave., ... | 800.5 mL in unit dose vials | Lack of Assurance of Sterility: FDA inspection found the recalled products were produced in a manner than cannot guar... | Class II | D-0053-2023 |
| Aug 26, 2022 | Carolina Infusion | Semaglutide/Cyanocobalamin 24/2 MG/ML Injectable, 0.4 ML syringe, Rx only, Carolina Infusion LLC, 95 Bees Creek Road, Ridgeland, SC 29936. | 4 syringes | Lack of Assurance of Sterility | Class II | D-1521-2022 |
| Aug 26, 2022 | Carolina Infusion | Semaglutide/Cyanocobalamin 5/2 MG/ML Injectable, 0.2 ML syringe, Rx only, Carolina Infusion LLC, 95 Bees Creek Road, Ridgeland, SC 29936. | 24 syringes | Lack of Assurance of Sterility | Class II | D-1519-2022 |
| Aug 26, 2022 | Carolina Infusion | Semaglutide/Cyanocobalamin 10/2 MG/ML Injectable, 0.4 ML syringe, Rx only, Carolina Infusion LLC, 95 Bees Creek Road, Ridgeland, SC 29936. | 4 syringes | Lack of Assurance of Sterility | Class II | D-1520-2022 |
| Mar 7, 2022 | TMC Acquisition LLC dba Tailor Made Compounding | Semaglutide/Cyanocobalamin 5mg/0.2mg/ml, 2ml-vial, Refrigerate, Tailor Made Compounding | 9,993 vials | Lack of Assurance of Sterility | Class II | D-1225-2022 |
| Mar 7, 2022 | TMC Acquisition LLC dba Tailor Made Compounding | Semaglutide/Cyanocobalamin 2mg/0.4mg/ml, 1mL-vial, Refrigerate, Tailor Made Compounding | 5,842 vials | Lack of Assurance of Sterility | Class II | D-1224-2022 |
All GLP-1 recall reports
Across all tracked drugs, openFDA lists 81 recall reports: 52 naming semaglutide, 28 naming tirzepatide, 1 naming retatrutide.
| Record | ||||||
|---|---|---|---|---|---|---|
| Sep 25, 2026 | Houston Rx LLC | Tirzepatide/Niacinamide 2mL vial (40 MG per Vial) Inj 20mg/2mg/mL, RX Only, Houston RX LLC, 15430 Vantage Parkway E STE 220, Houston, TX 77032. | Lack of assurance of sterility. | Class II | Ongoing | D-0040-2027 |
| Sep 24, 2026 | Apothecary Pharma LLC | Tirzepatide Injection, 18mg/mL, 4 mL Sterile Multi-Dose Vial, Rx only, Apothecary Pharma, LLC, 1913 Evans Road, Cary, NC 27513, NDC 85091-001-18. | Lack of Assurance of Sterility | Class II | Ongoing | D-0036-2027 |
| Sep 10, 2026 | Carolina Infusion, LLC | TIRZEPATIDE/CYANOCOBALAMIN 26/2 MG/ML INJECTABLE, Packaged in single-use dosage syringes, total mL dispensed based on dosage per specific patient prescriptio... | Lack of Assurance of Sterility: Related to formulation using bacteriostic water; Related to processing equipment used in compounded product. | Class II | Ongoing | D-0027-2027 |
| Sep 10, 2026 | Carolina Infusion, LLC | TIRZEPATIDE/CYANOCOBALAMIN 85/2 MG/ML INJECTABLE, Packaged in single-use dosage syringes, total mL dispensed based on dosage per specific patient prescriptio... | Lack of Assurance of Sterility: Related to formulation using bacteriostic water; Related to processing equipment used in compounded product. | Class II | Ongoing | D-0030-2027 |
| Sep 10, 2026 | Carolina Infusion, LLC | TIRZEPATIDE/CYANOCOBALAMIN 64/2 MG/ML INJECTABLE, Packaged in single-use dosage syringes, total mL dispensed based on dosage per specific patient prescriptio... | Lack of Assurance of Sterility: Related to formulation using bacteriostic water; Related to processing equipment used in compounded product. | Class II | Ongoing | D-0028-2027 |
| Sep 10, 2026 | Carolina Infusion, LLC | TIRZEPATIDE/CYANOCOBALAMIN 76/2 MG/ML INJECTABLE, Packaged in single-use dosage syringes, total mL dispensed based on dosage per specific patient prescriptio... | Lack of Assurance of Sterility: Related to formulation using bacteriostic water; Related to processing equipment used in compounded product. | Class II | Ongoing | D-0029-2027 |
| Sep 10, 2026 | Carolina Infusion, LLC | TIRZEPATIDE 26 MG/ML INJECTABLE, Packaged in single-use dosage syringes, total mL dispensed based on dosage per specific patient prescription, Carolina Infus... | Lack of Assurance of Sterility: Related to formulation using bacteriostic water; Related to processing equipment used in compounded product. | Class II | Ongoing | D-0017-2027 |
| Feb 26, 2026 | New Life Pharma LLC | Tirzepatide Inj, 15mg x 4, Sterile Multi-Dose Vial, Rx only, Nomida, 25055 W Valley Pkwy, Suite 106, Olathe, KS 66061, NDC 84223-002-04. | Lack of Assurance of Sterility | Class II | Ongoing | D-0395-2026 |
| Feb 26, 2026 | New Life Pharma LLC | Tirzepatide Inj, 10mg, Sterile Multi-Dose Vial, Rx only, Nomida, 25055 W Valley Pkwy, Suite 106, Olathe, KS 66061, NDC 84223-002-03. | Lack of Assurance of Sterility | Class II | Ongoing | D-0394-2026 |
| Oct 15, 2025 | ProRx LLC | Tirzepatide Injection, 27 mg/3 mL (9 mg/mL), 3mL Multidose Vial, For Subcutaneous Use, Rx Only, Mfd by: ProRx, 619 Jeffers Cir, Exton, PA 19341. NDC: 84139... | Lack of Assurance of Sterility | Class II | Ongoing | D-0120-2026 |
| Jul 30, 2025 | GenoGenix LLC | Tirzepatide, 60mg/10 mL for Injection, 10mL vial lyophilized, all presentations, GenoGenix, LLC, 2840 NW 2nd Ave Ste 204 Boca Raton, FL 33431-6692. Also labe... | Lack of Assurance of Sterility | Class II | Ongoing | D-0092-2026 |
| Jul 30, 2025 | GenoGenix LLC | Retatrutide for Injection, 60mg / 10mL vial, all presentations, GenoGenix, LLC, 2840 NW 2nd Ave Ste 204 Boca Raton, FL 33431-6692 | Lack of Assurance of Sterility | Class II | Ongoing | D-0093-2026 |
| Jul 18, 2025 | AEQUITA PHARMACY | Tirzepatide + Niacinamide 4.4 mg + 1.0mg/0.5 mL Inj Sol, Inject 0.5 mL (50 units on syringe) subcutaneously, Sterile, 2 mL Multi Dose Vial, Refrigerate, Do n... | Lack of Processing Controls. | Class II | Ongoing | D-0555-2025 |
| Jul 18, 2025 | AEQUITA PHARMACY | Tirzepatide + Niacinamide 2.2 mg + 1.0mg/0.5 mL Inj Sol, Inject 0.5 mL (50 units on syringe) subcutaneously, Sterile, 2mL Multi Dose Vial, Refrigerate, Do no... | Lack of Processing Controls. | Class II | Ongoing | D-0554-2025 |
| Jul 18, 2025 | AEQUITA PHARMACY | Tirzepatide + Niacinamide 11.24 mg + 1.0mg/0.5 mL Inj Sol, Inject 0.5 mL (50 units on syringe) subcutaneously, Sterile, 2 mL Multi Dose Vial, Refrigerate, D... | Lack of Processing Controls. | Class II | Ongoing | D-0558-2025 |
| Jul 18, 2025 | AEQUITA PHARMACY | Tirzepatide + Niacinamide 16.6 mg + 1.0mg/0.5 mL Inj Sol, Inject 0.5 mL (50 units on syringe) subcutaneously, Sterile, 3 x 2 mL Multi Dose Vial, Refrigerate... | Lack of Processing Controls. | Class II | Ongoing | D-0560-2025 |
| Jul 18, 2025 | AEQUITA PHARMACY | Tirzepatide + Niacinamide 6.6 mg + 1.0mg/0.5 mL Inj Sol, Inject 0.5 mL (50 units on syringe) subcutaneously, Sterile, 2 mL Multi Dose Vial, Refrigerate, Do ... | Lack of Processing Controls. | Class II | Ongoing | D-0556-2025 |
| Jul 18, 2025 | AEQUITA PHARMACY | Tirzepatide + Niacinamide 8.8 mg + 1.0mg/0.5 ml Inj Sol, Inject 0.5 mL (50 units on syringe) subcutaneously, Sterile, 2 mL Multi Dose Vial, Refrigerate, Do ... | Lack of Processing Controls. | Class II | Ongoing | D-0557-2025 |
| Jul 18, 2025 | AEQUITA PHARMACY | Tirzepatide + Niacinamide 13.2 mg + 1.0mg/0.5 mL Inj Sol, Inject 0.5 mL (50 units on syringe) subcutaneously, Sterile, 2 mL Multi Dose Vial, Refrigerate, Do ... | Lack of Processing Controls. | Class II | Ongoing | D-0559-2025 |
| May 21, 2025 | Thrive Health and Wellness, LLC, dba Thrive Health Solutions (Colorado) | Tirzepatide Injections, 30mg/mL, pre-filled syringe, Thrive Health Solutions, 88 Inverness, Cir E, Suite A-204, Englewood, CO 80112 | Lack of Assurance of Sterility | Class II | Ongoing | D-0484-2025 |
| May 21, 2025 | Thrive Health and Wellness, LLC, dba Thrive Health Solutions (Colorado) | Tirzepatide/Cyanocobalamin Injectable, 15mg/1mg/mL, pre-filled syringe, Thrive Health Solutions, 88 Inverness, Cir E, Suite A-204, Englewood, CO 80112 | Lack of Assurance of Sterility | Class II | Ongoing | D-0485-2025 |
| May 21, 2025 | Thrive Health and Wellness, LLC, dba Thrive Health Solutions (Colorado) | Tirzepatide Injections, 10mg/mL, pre-filled syringe, Thrive Health Solutions, 88 Inverness, Cir E, Suite A-204, Englewood, CO 80112 | Lack of Assurance of Sterility | Class II | Ongoing | D-0482-2025 |
| May 21, 2025 | Thrive Health and Wellness, LLC, dba Thrive Health Solutions (Colorado) | Tirzepatide/Cyanocobalamin Injectable, 30mg/1mg/mL (15mg/0.5mg/0.5mL), pre-filled syringe, Thrive Health Solutions, 88 Inverness, Cir E, Suite A-204, Englewo... | Lack of Assurance of Sterility | Class II | Ongoing | D-0486-2025 |
| May 21, 2025 | Thrive Health and Wellness, LLC, dba Thrive Health Solutions (Colorado) | Tirzepatide Injections, 20mg/mL, pre-filled syringe, Thrive Health Solutions, 88 Inverness, Cir E, Suite A-204, Englewood, CO 80112 | Lack of Assurance of Sterility | Class II | Ongoing | D-0483-2025 |
| Aug 22, 2024 | ProRx LLC | Tirzepatide 2 mL (10 mg/mL) and 20 mg/mL, 2mL Multidose SC Injection vials, Compounded Rx Product, ProRx 267-565-7008, NDC 84139-210-01 | Lack of Assurance of Sterility | Class II | Ongoing | D-0651-2024 |
| Aug 22, 2024 | ProRx LLC | TIRZEPATIDE 60 mg/3mL (20/mg/mL), Rx Only, 3mL Multiple Dose Vial, Mfd by: ProRx Exton, PA, 19341, NDC 84139-210-02 | Lack of Assurance of Sterility | Class II | Ongoing | D-0656-2024 |
| Aug 22, 2024 | ProRx LLC | TIRZEPATIDE 20 mg/2mL (10/mg/mL), Rx Only, 2mL Multiple Dose Vial, Mfd by: ProRx Exton, PA, 19341, NDC 84139-210-01 | Lack of Assurance of Sterility | Class II | Ongoing | D-0655-2024 |
| Apr 20, 2024 | Revive Rx LLC dba Revive Rx Pharmacy | Tirzepatide 10 mg/0.5 mL Sterile Solution, 2 mL Multi-dose vial, Rx only, This is a Compounded Product By: Revive RX Pharmacy, 3831 Golf Dr A, Houston, TX 77... | Labeling: Label Mix-up - product labeled as tirzepatide contains testosterone cypionate | Class I | Ongoing | D-0511-2024 |
| May 11, 2023 | Revive Rx LLC dba Revive Rx Pharmacy | Tirzepatide 10 mg/0.5 mL Sterile Solution-2 mL Vial, Rx Only, For Sub-Q Use Only, Compounded Drug Product By: Revive Rx, 3831 Golf Dr A, Houston, TX 77018, N... | Sub-potent Drug | Class II | Ongoing | D-0771-2023 |
Common questions
Which compounded tirzepatide products have been recalled?
28 openFDA recall reports name tirzepatide as of Nov 15, 2026. They are in the second table on this page and on the tirzepatide page.
What do Class I and Class II mean?
FDA assigns the class. FDA defines Class I as situations with a reasonable probability of serious adverse health consequences, and Class II as situations that may cause temporary or medically reversible consequences or where serious consequences are remote.
This page lists recall enforcement reports as FDA publishes them through openFDA. A recall record is not a finding by this site. Follow each link for the original record. Report an error or add a company response.
Sources
Records last pulled Nov 15, 2026. Every entry links to the original public record.